Orchard Therapeutics PLC
Leonie Martin is currently serving as the Senior Director Clinical Operations at Orchard Therapeutics. With a background in pharmacology and extensive experience in clinical research and project management, Leonie has worked with various pharmaceutical companies such as IQVIA, Aimmune Therapeutics, and Takeda. Leonie has managed global clinical trials in different therapeutic areas, including Gastroenterology, Oncology, and Diabetes. Leonie's expertise includes overseeing study operations, budget management, site management, and adherence to regulatory guidelines. Leonie's career trajectory showcases a strong foundation in clinical research and a commitment to advancing healthcare through efficient and ethical trial conduct.
This person is not in any offices
Orchard Therapeutics PLC
3 followers
Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.